Pharmacy manufacturing education in India was also a key part of the drug wars.
Pharmaceutical industry was forced to face down the Congress government in the 1990s and the Modi government in 2014, who came to power in 2014.
The Indian pharmaceutical industry had not been able to survive without manufacturing and distributing medicines, the government’s official data shows.
“In the 1990’s, pharma manufacturing education was the only option for the industry.
Today, it is only a matter of time,” said Manoj Kumar, a senior fellow at the Centre for Policy Research.
The pharmaceutical industry was not only facing a war against drug pricing but also an economic blockade, said Kumar.
It had lost around half its annual revenue to the pharmaceutical industry in the last decade and the market share of the Indian pharmaceutical companies was declining.
Drug manufacturers and wholesalers were forced to negotiate the lowest price possible with the government, Kumar said.
They have been trying to maintain the quality of medicines by manufacturing them in India at lower cost, he said.
India had one of the lowest drug prices in the world and was one of India’s top manufacturing hubs for pharmaceuticals.
Kumar, who is also a former chief of the pharmaceutical research agency at the National Institute of Health Sciences (NIRS), said the pharmaceuticals companies were trying to preserve the profit margins and keep costs down.
“Pharmaceuticals are expensive.
They are expensive to manufacture, and they are expensive in terms of the cost of the drugs they are making.
So they need to come up with low prices and keep prices low,” Kumar said, adding that the cost for a prescription in India is around US$50,000.
The Indian government did not respond to a request for comment.